38.13 -15.05 7.90 5.48 - Total gross profit 275.59 86.25 219.52 208.54 143.57 45.25 Selling & Marketing expenses 125.39 66.65 88.13 67.17 50.29 33.57 Administrative expenses 92.50 73.73 25.46 77.89 64.42
(10.68) Operating cost 596.69 621.42 (24.73) Gross profit 110.53 96.48 14.05 Gross profit margin 15.63% 13.44% 2.19% Other income 3.80 1.99 1.81 Selling expenses 2.13 3.04 (0.91) Administrative expenses
profits rate from the previous year because of the increase of the Company’s profit capacity. Although, the Company incurred the increased selling and administration expenses comparing to the same period of
, the Company slightly increased its EBITDA profits rate from the previous year because of the increase of the Company’s profit capacity. Although, the Company incurred the increased selling and
evidence of earnings management. In other words, if there is no economic incentive for meeting or beating earnings benchmarks, reported earnings distribution is assumed to be even and smooth around presumed
period ended June 30, 2017. The Group's sales and net profit totaled Bt3,663.5 million and Bt672.3 million, respectively, compared to Bt3,578.6 million and Bt811.8 million in the second quarter of 2016. A
period ended September 30, 2017. The Group's sales and net profit totaled Bt3,602.0 million and Bt612.4 million, respectively, compared to Bt3,515.2 million and Bt786.0 million in the third quarter of 2016
from construction and services such as the Southern Science Park Administration Building Project, the Fine Arts Department Office Building, the Somdech Phra Pinklao Hospital Building Nava Medical
เรื่อง ธนาคารแห่งประเทศไทยขอความร่วมมือในการป้องปรามการเก็งกำไรค่าเงินบาท
ความเห็นเกี่ยวกับการเปิดเผยข้อมูลการกันกำไรสะสมเป็นสำรองสำหรับหุ้นซื้อคืน